Norihiro Kobayashi
Overview
Explore the profile of Norihiro Kobayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
180
Citations
1087
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mori S, Hirano K, Setonaga Y, Kishida T, Fukagawa T, Yamaguchi K, et al.
Health Sci Rep
. 2025 Jan;
8(1):e70391.
PMID: 39867716
Background And Aims: When dealing with severely calcified lesions in endovascular therapy (EVT) for lower extremity artery disease (LEAD), navigating through severely calcified chronic total occlusion (CTO) using hard-tip guidewires...
2.
Kishida T, Mori S, Yamaguchi K, Tsutsumi M, Kobayashi N, Ito Y
CVIR Endovasc
. 2024 Dec;
7(1):86.
PMID: 39644409
Background: Lower limb peripheral artery disease classified as Rutherford category IV, is characterized by lower limb ischemic pain both during exertion and at rest. This disease has an unclear course....
3.
Fukagawa T, Mori S, Yamawaki M, Kobayashi N, Ito Y
J Endovasc Ther
. 2024 Nov;
:15266028241296044.
PMID: 39540610
Introduction: In the current study, we hypothesized that the Japanese below-the-knee chronic total occlusion score could be used to stratify the lesion difficulty of endovascular therapy for below-the-knee chronic total...
4.
Kozai Y, Mori S, Mizusawa M, Shirai S, Honda Y, Tsutsumi M, et al.
Heart Vessels
. 2024 Sep;
40(3):251-257.
PMID: 39316099
In drug-coated balloon (DCB) angioplasty for femoropopliteal lesions, there are adverse effects of drug embolization on downstream non-target organs following the slow-flow phenomenon. We devised a novel method, known as...
5.
Mori S, Kobayashi N, Tsutsumi M, Ito Y
Clin Case Rep
. 2024 Aug;
12(8):e9233.
PMID: 39091618
Under challenging common femoral artery access scenarios, the "wall PIERCE" technique, which utilizes a larger puncture needle to pierce the vessel wall along the guidewire, facilitates sheath insertion. This method...
6.
Ohgita T, Sakai K, Fukui N, Namba N, Nakano M, Kiguchi Y, et al.
FEBS Lett
. 2024 Mar;
598(8):902-914.
PMID: 38529702
Apolipoprotein E (apoE) is a regulator of lipid metabolism, cholesterol transport, and the clearance and aggregation of amyloid β in the brain. The three human apoE isoforms apoE2, apoE3, and...
7.
Kiguchi Y, Morita I, Yamaki K, Takegami S, Kobayashi N
Biol Pharm Bull
. 2023 Dec;
46(12):1661-1665.
PMID: 38044090
We generated three single-chain Fv fragments (scFvs) specific to cortisol according to our original affinity-maturation strategy and verified their utility in developing immunoassays. These scFv mutants (m-scFvs) had insertion of...
8.
Bavishi C, Davies R, Matsuno S, Kobayashi N, Katoh H, Obunai K, et al.
J Cardiol
. 2023 Oct;
83(4):272-279.
PMID: 37863185
Advances in percutaneous coronary intervention (PCI) devices and techniques have expanded the pool of eligible patients for revascularization, including those with comorbidities, reduced left ventricular function, or anatomical complexity (defined...
9.
Yamaguchi K, Mori S, Fukagawa T, Kishida T, Nakano T, Shirai S, et al.
Indian Heart J
. 2023 Sep;
75(6):403-408.
PMID: 37739220
Objectives: We analyzed the 2-year clinical outcomes of patients with de novo femoropopliteal (FP) lesions who underwent drug-coated balloon (DCB) angioplasty and the angiographic predictors of restenosis. Methods: This single-center,...
10.
Ohgita T, Kono H, Morita I, Oyama H, Shimanouchi T, Kobayashi N, et al.
Sci Rep
. 2023 Jul;
13(1):10885.
PMID: 37407638
Regulation of α-synuclein (αS) fibril formation is a potent therapeutic strategy for αS-related neurodegenerative disorders. αS, an intrinsically disordered 140-residue intraneural protein, comprises positively charged N-terminal, hydrophobic non-amyloid β component...